
Hyperbaric oxygen treatment on keloid tumor immune gene expression
Author(s) -
Wang Chun-hu,
Mengjie Shan,
Hao Liu,
Yan Hao,
Kexin Song,
Huanwen Wu,
Meng Tian,
Cheng Feng,
Qi Zheng,
Zhi Wang,
Youbin Wang
Publication year - 2021
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.1097/cm9.0000000000001780
Subject(s) - keloid , immune system , cd80 , cd8 , cancer research , immunohistochemistry , gene expression , interleukin , immunology , medicine , biology , pathology , gene , cytokine , cytotoxic t cell , biochemistry , cd40 , in vitro
Hyperbaric oxygen treatment (HBOT) has been demonstrated to influence the keloid recurrence rate after surgery and to relieve keloid symptoms and other pathological processes in keloids. To explore the mechanism of the effect of HBOT on keloids, tumor immune gene expression and immune cell infiltration were studied in this work.